Perspectives of Transporter-Mediated Drug Interactions in Drug Development

First Page		Document Content
Pharmaceutical industry Medicinal chemistry ABC transporters Drug discovery P-glycoprotein Lapatinib ADME Efflux Drug development Pharmaceutical sciences Chemistry Pharmacology		Perspectives of Transporter-Mediated Drug Interactions in Drug Development Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 292,49 KB Share Document on Facebook

	Microsoft PowerPoint - XBL-Liposomal ADME_DHeller_Nanjing_2014_final modified layout.pptx DocID: 1unS1 - View Document
	SeeSAR™ — Every Chemist‘s SAR and ADME Dashboard Expect Actives Visual 3D Guidance for Lead Optimization for bench chemists and experts alike Entropy-aware ∆G estimates, torsional analyses, and explorability — DocID: 1nM6E - View Document
	PDF Document DocID: 1nwjr - View Document
	Post-doctoral position in Computational Chemistry AstraZeneca Research Centre Reims (France). As part of our expanding commitment to ADME targeted molecular design in early phase drug discovery, we have created this new DocID: 1mfo2 - View Document
	DMC Competencies Client Meeting/ Event Goals History DocID: 1khC8 - View Document